Counting What Cannot Be Seen: Pressure-Testing Environmental Monitoring in UK Cell and Gene Therapy Cleanrooms
Many UK cell and gene therapy facilities run environmental monitoring plans inherited from conventional pharmaceutical manufacturing, then discover that small batches and short campaigns break the assumptions behind them. This is a practical 2026 framework for risk-based monitoring, fragile trending data and proportionate contamination response.